NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/10/2023
Voltar para busca
Dado oficial do USPTO
OPTELLUM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
10/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
08/04/2021
Data de registro
10/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/10/2023
Última transação
10/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Oxford, Oxfordshire, GB
Examinador
KOVALSKY, LAURA G
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Optellum Limited
Representantes
Joshua M. Gerben, Esq. GERBEN PERROTT PLLC
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable software for analyzingtrackingmonitoring pulmonary diseaseoptimizing diagnosis of the development of pulmonary diseaseusing artificial intelligence for detecting early lung cancer and cancerclinicians to identify and track at-risk patients in the field of medicineuse in the field of managementdiagnosiscare of patients in the field of lung and pulmonary medicineusing data to guide lung cancer managementusing data of computed tomography scansuse with radiology reportsuse with patient recordsuse in medical decision support systems; Downloadable computer application software for analyzingtrackingmonitoring pulmonary diseaseoptimizing diagnosis of the development of pulmonary diseaseusing artificial intelligence for detecting early lung cancer and cancerclinicians to identify and track at-risk patients in the field of medicineuse in the field of managementdiagnosiscare of patients in the field of lung and pulmonary medicineusing data to guide lung cancer managementusing data of computed tomography scansuse with radiology reportsuse with patient recordsuse in medical decision support systems
Classe 42
Software as a service (SAAS) services featuring software for analyzingtrackingmonitoring pulmonary diseaseoptimizing diagnosis of the development of pulmonary diseaseusing artificial intelligence for detecting early lung cancer and cancerclinicians to identify and track at-risk patients in the field of medicineuse in the field of managementdiagnosiscare of patients in the field of lung and pulmonary medicineusing data to guide lung cancer managementusing data of computed tomography scansuse with radiology reportsuse with patient recordsuse in medical decision support systems; Platform as a service (PAAS) featuring computer software platforms for analyzingtrackingmonitoring pulmonary diseaseoptimizing diagnosis of the development of pulmonary diseaseusing artificial intelligence for detecting early lung cancer and cancerclinicians to identify and track at-risk patients in the field of medicineuse in the field of managementdiagnosiscare of patients in the field of lung and pulmonary medicineusing data to guide lung cancer managementusing data of computed tomography scansuse with radiology reportsuse with patient recordsuse in medical decision support systems; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for analyzingtrackingmonitoring pulmonary diseaseoptimizing diagnosis of the development of pulmonary diseaseusing artificial intelligence for detecting early lung cancer and cancerclinicians to identify and track at-risk patients in the field of medicineuse in the field of managementdiagnosiscare of patients in the field of lung and pulmonary medicineusing data to guide lung cancer managementusing data of computed tomography scansuse with radiology reportsuse with patient recordsuse in medical decision support systems; Providing temporary use of non-downloadable cloud-based software for analyzingtrackingmonitoring pulmonary diseaseoptimizing diagnosis of the development of pulmonary diseaseusing artificial intelligence for detecting early lung cancer and cancerclinicians to identify and track at-risk patients in the field of medicineuse in the field of managementdiagnosiscare of patients in the field of lung and pulmonary medicineusing data to guide lung cancer managementusing data of computed tomography scansuse with radiology reportsuse with patient recordsuse in medical decision support systems; Providing temporary use of non-downloadable cloud-based software for connectingoperatingmanaging networked medical devices and medical machines in the internet of things (IoT); Providing temporary use of on-line non-downloadable software and applications for analyzingtrackingmonitoring pulmonary diseaseoptimizing diagnosis of the development of pulmonary diseaseusing artificial intelligence for detecting early lung cancer and cancerclinicians to identify and track at-risk patients in the field of medicineuse in the field of managementdiagnosiscare of patients in the field of lung and pulmonary medicineusing data to guide lung cancer managementusing data of computed tomography scansuse with radiology reportsuse with patient recordsuse in medical decision support systems; medical research services in the field of pulmonary disease and diagnosis
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/07/2023
PUBO
PUBLISHED FOR OPPOSITION
25/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/07/2023
OTHE
CASE RETURNED TO EXAMINATION
21/06/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
15/06/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
15/06/2023
ERTI
TEAS RESPONSE TO PETITION INQUIRY LETTER
12/06/2023
PILM
PETITION INQUIRY LETTER ISSUED
06/06/2023
APET
ASSIGNED TO PETITION STAFF
06/06/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/06/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
29/05/2023
44EP
44(e) PETITION - RECEIVED
19/04/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
19/04/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
29/11/2022
NEWN
NEW NOA TO ISSUE
17/10/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/07/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
26/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/05/2022
PUBO
PUBLISHED FOR OPPOSITION
31/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/04/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/11/2021
GNRT
NON-FINAL ACTION E-MAILED
30/11/2021
CNRT
NON-FINAL ACTION WRITTEN
30/11/2021
DOCK
ASSIGNED TO EXAMINER
29/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/07/2021
NWAP
NEW APPLICATION ENTERED
12/04/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OPTELLUM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.